Locations
Cambridge, MA, USA · North America · saint-laurent, montreal, qc, canada · Bas-Saint-Laurent, QC, Canada · Montréal, QC, Canada
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2016
Repare Therapeutics is a leading clinical-stage precision oncology company focused on synthetic lethality. Utilizing their proprietary SNIPRx® platform, they systematically discover and develop targeted cancer therapies that address genomic instability, particularly in DNA damage repair. Founded in 2016 by leading academics, the company aims to be a leader in biopharmaceuticals by developing small molecule therapies based on synthetic lethality, identifying novel targets, designing selective inhibitors, and expanding treatment options for patients with high unmet medical needs.
Something looks off?